Hannah Bergin1,2, Gillian Wood2, Susan P Walker1,2, Lisa Hui1,2. 1. Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia. 2. 2Department of Perinatal Medicine, Mercy Hospital for Women, Melbourne, Victoria, Australia.
Abstract
OBJECTIVE: To evaluate the implementation of the 2013 Royal Australian and New Zealand College of Obstetricians and Gynaecologists 'Management of Hepatitis B in Pregnancy' guideline. METHODS: Retrospective cohort study of the clinical management and obstetric outcomes among hepatitis B virus-positive women in a single tertiary maternity hospital. Women with viral load >200,000 IU/ml were referred to a specialised clinic for consideration of tenofovir disoproxil fumarate therapy to reduce mother to child transmission. RESULTS: A total of 11,496 women gave birth during the study period, of which 101 (0.9%) women were hepatitis B virus positive. Viral load was measured in 99 (98%) of 101 hepatitis B virus-positive women; 30 (30%) had a viral load >200,000 IU/ml. Twenty-six women accepted tenofovir disoproxil fumarate; of these, 23 had a successful virological response (viral load <200,000 IU/ml before delivery). CONCLUSIONS: Adherence to updated management guidelines and patient acceptance of tenofovir disoproxil fumarate in our Australian population were high when provided in the context of a dedicated perinatal service.
OBJECTIVE: To evaluate the implementation of the 2013 Royal Australian and New Zealand College of Obstetricians and Gynaecologists 'Management of Hepatitis B in Pregnancy' guideline. METHODS: Retrospective cohort study of the clinical management and obstetric outcomes among hepatitis B virus-positive women in a single tertiary maternity hospital. Women with viral load >200,000 IU/ml were referred to a specialised clinic for consideration of tenofovir disoproxil fumarate therapy to reduce mother to child transmission. RESULTS: A total of 11,496 women gave birth during the study period, of which 101 (0.9%) women were hepatitis B virus positive. Viral load was measured in 99 (98%) of 101 hepatitis B virus-positive women; 30 (30%) had a viral load >200,000 IU/ml. Twenty-six women accepted tenofovir disoproxil fumarate; of these, 23 had a successful virological response (viral load <200,000 IU/ml before delivery). CONCLUSIONS: Adherence to updated management guidelines and patient acceptance of tenofovir disoproxil fumarate in our Australian population were high when provided in the context of a dedicated perinatal service.
Entities:
Keywords:
Hepatology; drugs (medication); gastroenterology; infectious diseases; perinatal medicine
Authors: Michelle Giles; Kumar Visvanathan; Sharon Lewin; Scott Bowden; Stephen Locarnini; Tim Spelman; Joe Sasadeusz Journal: Gut Date: 2014-11-27 Impact factor: 23.059
Authors: Astrid-Jane Greenup; Pok Kern Tan; Vi Nguyen; Anne Glass; Scott Davison; Ushmi Chatterjee; Susan Holdaway; Dev Samarasinghe; Kathy Jackson; Stephen A Locarnini; Miriam T Levy Journal: J Hepatol Date: 2014-05-05 Impact factor: 25.083
Authors: Robert S Brown; Brian J McMahon; Anna S F Lok; John B Wong; Ahmed T Ahmed; Mohamed A Mouchli; Zhen Wang; Larry J Prokop; Mohammad Hassan Murad; Khaled Mohammed Journal: Hepatology Date: 2015-11-13 Impact factor: 17.425
Authors: Tram T Tran; Stuart C Gordon; Scott Fung; Phillip Dinh; Leland Yee; Eduardo Bruno Martins; Maria Buti; Patrick Marcellin Journal: PLoS One Date: 2015-03-19 Impact factor: 3.240